APA (7th ed.) Citation

J, Z., R, S., N, K., X, Y., Y, L., & A, M. (2026). Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 40(4), 567. https://doi.org/10.1007/s40259-026-00785-x

Chicago Style (17th ed.) Citation

J, Zhong, Song R, Kerrouche N, Yu X, Levin Y, and Mor A. "Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 40, no. 4 (2026): 567. https://doi.org/10.1007/s40259-026-00785-x.

MLA (9th ed.) Citation

J, Zhong, et al. "Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 40, no. 4, 2026, p. 567, https://doi.org/10.1007/s40259-026-00785-x.